CG Oncology Aktie
WKN DE: A3EKLQ / ISIN: US1569441009
|
09.10.2025 00:14:14
|
Why Cg Oncology Stock Rocketed 7% Higher Today
Highly specialized biotech CG Oncology (NASDAQ: CGON) was the subject of a new research report Wednesday, and its bullish tone helped lift the company's share price. This improved by more than 7% on the day, easily beating the 0.6% advance of the bellwether S&P 500 (SNPINDEX: ^GSPC). That publication marked the initiation of coverage on CG Oncology stock by veteran researcher Guggenheim, in the person of prognosticator Brad Canino. He rated the company's shares a buy at a price target of $90 per share, which is more than double their latest closing price. Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu CG Oncology Inc Registered Shsmehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu CG Oncology Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
| CG Oncology Inc Registered Shs | 42,98 | -1,67% |
|